Ramiro Ribeiro - 30 Jun 2026 Form 4 Insider Report for EyePoint, Inc. (EYPT)

Reporting relationship: Chief Medical Officer
Issuer ticker: EYPT
Reported as of: 30 Jun 2026
Net transaction value: -$73,167
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:03:22 UTC
Prior SEC filing: 20 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Ron Honig, Attorney-in-Fact

Key filing fact

Ramiro Ribeiro filed Form 4 for EyePoint, Inc. (EYPT) on 02 Jul 2026.

Key facts

This page summarizes Ramiro Ribeiro's Form 4 filing for EyePoint, Inc. (EYPT).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 16:03.

Change

Previous filing in this sequence was filed on 20 Apr 2026.
Current net transaction value: -$73,167.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013623 Primary reporting owner

Ribeiro Ramiro

Relationship: Chief Medical Officer
Address: C/O EYEPOINT, INC, 480 PLEASANT STREET, SUITE C400, WATERTOWN
Signature: /s/ Ron Honig, Attorney-in-Fact
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EYPT transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,437
Change %
Price: $8.26^*
Shares after: 2,437
Date: 30 Jun 2026
Ownership: Direct

EYPT transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,438
Change %: +100%
Price: $8.26^*
Shares after: 4,875
Date: 30 Jun 2026
Ownership: Direct

EYPT transaction

Common Stock

Sale

Transaction value: $36,555
Shares: -2,437
Change %: -50%
Price: $15.00
Shares after: 2,438
Date: 30 Jun 2026
Ownership: Direct

EYPT transaction

Common Stock

Sale

Transaction value: $36,612
Shares: -2,438
Change %: -100%
Price: $15.02
Shares after: 0
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EYPT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -2,437
Change %: -3%
Price: $0.000000^*
Shares after: 78,001
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,437
Exercise price: $8.26
Footnotes: F2

EYPT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -2,438
Change %: -3.1%
Price: $0.000000^*
Shares after: 75,563
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,438
Exercise price: $8.26
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.06. The reporting person undertakes to provide EyePoint Inc., any security holder of EyePoint Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.